Abuja, Nigeria – Thursday, September 11, 2025
Nigeria’s National Biotechnology Research and Development Agency (NBRDA) has partnered with China’s Shanghai Haiqi Industrial Company Ltd. to establish the country’s first insulin production plant.
The collaboration was formalized through a Memorandum of Agreement (MoA) signed in Abuja on September 10, 2025. The initiative aims to reduce Nigeria’s reliance on imported insulin, improve access to affordable insulin for diabetic patients, and save billions of Naira in foreign exchange annually.
Minister of Innovation, Science and Technology, Uche Nnaji, highlighted that the project would not only address a critical health need but also create jobs, build local technical expertise, and position Nigeria as a regional hub for medical biotechnology. Shanghai Haiqi Industrial Company’s General Manager, Bokai Zhai, expressed the company’s commitment to transferring technology and supporting Nigeria’s pharmaceutical industry.
